Eden Brew uses a precision fermentation platform based on CSIRO-developed science to produce casein proteins that it says deliver the nutrition, functionality, sensory qualities and bioavailability of cow’s milk. The company was established in 2021 through a partnership between Norco, CSIRO and Main Sequence Ventures. Its core product focus is animal-free dairy ingredients and it plans to pilot its platform at commercial scale and expand research and manufacturing operations in Victoria. Eden Brew will move its head office to Melbourne and introduce a new ice cream product targeted at the food service industry. The company is pursuing regulatory and patent approvals in Australia, where precision fermentation-derived proteins are treated as novel foods requiring pre-market authorization. Financially, Eden Brew has completed a Series A and previously raised capital in 2022 to support scale-up and commercialization efforts.

Total raised

$24M

Funding rounds

1

Latest round

Series A

Latest activity

Oct 2023